Why the study?
Does previous treatment with low doses of anthracyclines reduce ventricular systolic reserve in asymptomatic children?
Does previous treatment with low doses of anthracyclines reduce ventricular systolic reserve in asymptomatic children?
Decreased systolic reserve induced by low-dose anthracyclines in asymptomatic children persists but remains stable over a 5-year period, suggesting a benign long-term course for mild cardiotoxicity.
Answers are grounded in this paper and cite their sources.
Persistent post-exercise systolic reserve reduction after low-dose anthracyclines warrants surveillance; leaves open whether it predicts clinical events in larger survivor cohorts.
BACKGROUND: The time course of mild cardiotoxicity induced by anthracycline remains unknown. The aim of this study was to evaluate the long-term evolution of decreased myocardial reserve in children previously treated with a cumulative dose of anthracycline up to 100 mg/m(2). PATIENTS AND METHODS: Twenty-seven asymptomatic cancer survival patients (25 with lymphoblastic leukemia), in continuous remission and off treatment for >12 months with no alterations in conventional echocardiograms were evaluated by exercise echocardiography at 37 ± 15.4 months (T1) and 101 ± 24 months (T2) after finishing treatment (ADRIA group). This group was compared with 25 healthy individuals (control group) similar to the ADRIA group with respect to age and body surface area (BSA). All individuals underwent treadmill exercise testing according to Bruce protocol. Echocardiograms were performed before and immediately after exercise. RESULTS: The groups were similar regarding cardiac structure and left ventricular (LV) systolic function at rest at T1 and T2. The growth of LV posterior wall thickness related to BSA was lower in the ADRIA group at T2. Post exercise, smaller LV ejection indexes and attenuated changes in the afterload in ADRIA group were observed at T1 and T2. CONCLUSION: The decreased systolic reserve induced by a low dose of anthracycline in asymptomatic children and adolescents remains unaffected over a 5-year period, suggesting that positive outcomes in chronic cardiotoxicity would be expected in patients with mild impairment after anthracycline treatment.
No takes yet. Share an insight, caveat, or question.
Guimarães-Filho et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: